Market revenue in 2024 | USD 11.0 million |
Market revenue in 2030 | USD 18.5 million |
Growth rate | 9.2% (CAGR from 2025 to 2030) |
Largest segment | Distal filters |
Fastest growing segment | Distal Occlusion Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters |
Key market players worldwide | Boston Scientific Corp, Edwards Lifesciences Corp, Abbott Laboratories, Medtronic PLC, Cardinal Health Inc, Innovative Cardiovascular Solutions, Transverse Medical, W.L. Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to embolic protection devices market will help companies and investors design strategic landscapes.
Distal filters was the largest segment with a revenue share of 51.82% in 2024. Horizon Databook has segmented the Australia embolic protection devices market based on distal occlusion devices, proximal occlusion devices, distal filters covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia embolic protection devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia embolic protection devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account